← Leaderboards
John Joseph Dennehy
Queens College
$423,500
Attributed
$423,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $231K · FY2021–22$250K$187.5K$125K$62.5K$0
'21
'22
Funding mix
By agency
NIH$423,500 · 1
By mechanism
R21$423,500 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Anti-Bacterial Agents”
- Bruce Blough · Research Triangle Institute$19,637,160
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$11,832,144
- Denis Marc Daigle · Venatorx Pharmaceuticals, Inc.$7,512,530
- Terry Roemer · Prokaryotics, Inc.$5,750,688
- Tobias Doerr · Cornell University$3,917,047
- Berthony Deslouches · University Of Pittsburgh At Pittsburgh$3,597,192
Research focus
Anti-Bacterial AgentsAntibiotic ResistanceAntibioticsAntibiotic TherapyAntimicrobialAntineoplastic AntibioticsAreaBacteriaBacterial GenomeBacterial InfectionsBacteriophagesBiological Adaptation To StressBiologyBypassCellsCellular StressCenters For Disease Control And Prevention (U.S.)CharacteristicsChemotherapyClinically RelevantCombating Antibiotic Resistant BacteriaCommunitiesContainmentAmbush